Skip to main navigation Skip to search Skip to main content

Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study

  • Paul A. Hamlin
  • , Ian W. Flinn
  • , Nina Wagner-Johnston
  • , Jan A. Burger
  • , Greg P. Coffey
  • , Pamela B. Conley
  • , Glenn Michelson
  • , Janet M. Leeds
  • , Kenneth Der
  • , Yvonne Kim
  • , Alice Sabalvaro-Torres
  • , Matt Birrell
  • , Anjali Pandey
  • , John T. Curnutte
  • , Manish R. Patel

Research output: Contribution to journal › Letter › peer-review

30   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study'. Together they form a unique fingerprint.
Sort by